Funder: Novo Nordisk
Due Dates (Anticipated): August 2026 (full application deadline, projected)
Funding Amounts: DKK 6–22 million per grant (approx. €800,000–€2.95 million) over 3–5 years; total call budget DKK 89 million
Summary: Supports large, non-commercial clinical trials in Denmark to advance patient treatment and healthcare quality through new medicines and technologies.
Key Information: This is a forecasted opportunity; all dates are projected based on the annual cycle.